Observing the epidemiology of visceral leishmaniasis in Emilia-Romagna
Visceral Leishmaniasis in Emilia-Romagna
This study looks at the rise in cases of visceral leishmaniasis in Bologna to see how to improve diagnosis and treatment for patients of all ages.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 6 Years to 90 Years |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 5 sites (Cesena, Forlì-Cesena and 4 other locations) |
| Trial ID | NCT06793111 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the epidemiology of visceral leishmaniasis (LV) in the Province of Bologna, where there has been a noted increase in cases since 2012. By conducting a retrospective prospective analysis, the study seeks to establish a scientific basis for developing guidelines that standardize diagnostic and therapeutic approaches to LV. The goal is to reduce diagnostic delays and improve treatment outcomes, while also identifying new strategies for disease control to minimize transmission. The study will include patients of all ages with a confirmed diagnosis of LV who provide informed consent.
Who should consider this trial
Good fit: Ideal candidates for this study are patients of any age with a microbiologically confirmed diagnosis of visceral leishmaniasis.
Not a fit: Patients who do not provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment protocols for visceral leishmaniasis, ultimately enhancing patient outcomes.
How similar studies have performed: While there have been studies on leishmaniasis, this specific observational approach focusing on the epidemiology in a regional context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients of any age with microbiologically established diagnosis of LV. * Obtaining Informed Consent. Exclusion Criteria: * not having obtained Informed Consent
Where this trial is running
Cesena, Forlì-Cesena and 4 other locations
- Ospedale M. Bufalini di Cesena, AUSL della Romagna — Cesena, Forlì-Cesena, Italy (Recruiting)
- Ospedale G.B. Morgagni L. Pierantoni di Forlì — Forlì, Forlì-Cesena, Italy (Recruiting)
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (Recruiting)
- Ospedale S. Maria delle Croci di Ravenna, AUSL della Romagna — Ravenna, Italy (Recruiting)
- Ospedale Infermi di Rimini, AUSL della Romagna — Rimini, Italy (Recruiting)
Study contacts
- Principal investigator: Pierluigi Viale, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Pierluigi Viale, MD
- Email: pierluigi.viale@unibo.it
- Phone: +390512143353
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.